Titelia

Holdings of Invesco Pharmaceuticals ETF

Invesco Exchange-Traded Fund Trust · 29 declared positions · as of Apr 30, 2026

Original filing · Net assets 333.1M $ · Ten largest lines: 45.8 % of the equity sleeve

Sector breakdown

  • Health care 43.6 %
  • Unattributed 56.4 %

Sector is not declared in Form N-PORT: this is a Titelia classification, decided company by company. The unattributed share is counted as such rather than spread over the others.

Currency breakdown

  • USD 100.0 %

The currency each line is denominated in, as declared. It does not follow the country: a French company listed in the United States is declared in dollars.

Country breakdown

  • US 94.2 %
  • IE 5.8 %

Shares computed on the equity sleeve, the only part this site carries.

CountryLinesValue (USD)Share
US27314.7M $94.21 %
IE219.3M $5.79 %

Positions

CompanySharesValue (USD)Weight
Pfizer Inc 650,39417.4M $5.21 %
Johnson & Johnson 71,69716.5M $4.95 %
AbbVie Inc 77,26716.3M $4.90 %
Amgen Inc 46,10116M $4.79 %
Eli Lilly & Co 16,95415.8M $4.76 %
Gilead Sciences Inc 119,55315.6M $4.70 %
Merck & Co Inc 142,42215.5M $4.67 %
Abbott Laboratories 154,07214M $4.20 %
Travere Therapeutics Inc 316,56813.3M $4.00 %
Corcept Therapeutics Inc 267,96612.5M $3.74 %
Ligand Pharmaceuticals Inc 51,70211.9M $3.56 %
United Therapeutics Corp 20,64511.8M $3.54 %
Liquidia Corp 291,20011.4M $3.43 %
Jazz Pharmaceuticals PLC 56,22911.4M $3.43 %
Harmony Biosciences Holdings Inc 346,77810.8M $3.25 %
Ocular Therapeutix Inc 1,091,69110.2M $3.07 %
ANI Pharmaceuticals Inc 127,44610.1M $3.04 %
Bristol-Myers Squibb Co 158,7079.6M $2.89 %
Innoviva Inc 417,4029.6M $2.88 %
Biogen Inc 50,0849.5M $2.85 %
Viatris Inc 608,5099.1M $2.73 %
Regeneron Pharmaceuticals, Inc. 12,6478.9M $2.68 %
Supernus Pharmaceuticals Inc 183,4018.8M $2.64 %
Amneal Pharmaceuticals Inc 666,8578.6M $2.58 %
Tarsus Pharmaceuticals Inc 130,3208.3M $2.49 %
Prestige Consumer Healthcare Inc 142,1088M $2.40 %
Perrigo Co PLC 669,1517.9M $2.38 %
Amphastar Pharmaceuticals Inc 353,3137.8M $2.33 %
Collegium Pharmaceutical Inc 216,4017.3M $2.19 %